Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.38
-0.25 (-3.77%)
Mar 19, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $301.35 million as of March 19, 2026. Its market cap has increased by 34.91% in one year.
Market Cap
301.35M
Enterprise Value
216.40M
1-Year Change
34.91%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $301.35M, a decrease of -44.03%. That is a compound annual growth rate of -9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 301.35M | 4.93% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 331.55M |
| Bicycle Therapeutics | 327.62M |
| XOMA Royalty | 325.15M |
| NovaBridge Biosciences | 325.12M |
| Immix Biopharma | 317.65M |
| AC Immune | 314.48M |
| Forte Biosciences | 311.29M |
| Armata Pharmaceuticals | 310.26M |